NCT07519200Completed
Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
This trial will evaluate the SHARE-MC educational intervention designed to address sexual health needs and related adjustment in women with metastatic breast cancer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 96 (actual)
- First submitted
- 2 Apr 2026
- Start date
- Feb 2025
- Primary completion date
- Apr 2026
- Lead sponsor
- Dana-Farber Cancer Institute
- Diseases
- Metastatic breast cancer
- NCT number
- NCT07519200
What you commit to
- Study type: Interventional
- Participants enrolled: 96
- From Feb 2025 to the primary completion date, Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Diagnosis of any cancer prior to age 18
- Prior participation in Dr. Bober's sexual health research studies or workshops; or previous appointments with Dr. Bober through the DFCI Sexual Health Program.
Other illness
- Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently
Other
- Has never been sexually active
Who the study is looking for
- Women diagnosed with metastatic breast cancer
- Age ≥ 18
- Functionally appropriate to participate in the intervention, as assessed by 3 functional assessment items from the EQ-5D (see Eligibility Screening, Appendix A)
- Bothered by significant sexual dysfunction as evidenced by a Female Sexual Functioning Index (FSFI) score of ≤26. (See Eligibility Screening, Appendix A)
- Ability to read and write in English
- Regular access to the internet
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dana-Farber Cancer Institute Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.